Angiotensin II, oxidative stress, and aneurysm formation
血管紧张素 II、氧化应激和动脉瘤形成
基本信息
- 批准号:7018548
- 负责人:
- 金额:$ 36.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-02-16 至 2007-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Abdominal aortic aneurysms (AAA) occur in approximately 3% of humans > 65 years of age and are characterized by localized structural deterioration of the aortic wall, leading to progressive aortic dilation, The morbidity and mortality associated with AAA are considerable. Surprisingly, however, little is known about the mechanisms responsible for aneurysm formation and progression. Recent histological studies in humans indicate that AAA are highly inflammatory in nature. The inflammatory response is associated with death of smooth muscle cells (SMC) and degradation of matrix proteins by matrix metalloproteinases (MMP) that causes weakening of the aortic wall, and, consequently, dilation. Given that reactive oxygen species (ROS) are produced during inflammation and can induce SMC death and MMP activation, we hypothesize that ROS play a pivotal role in AAA formation. As an initial step to investigate this hypothesis, we examined human aneurysm tissue removed at the time of elective AAA repair. Our studies indicate that levels of superoxide and lipid peroxidation products, an index of tissue injury caused by oxidative stress, are markedly increased in AAA as compared with adjacent, non-aneurysmal aortic tissue obtained from the same patients. We also detected increased expression and activity of NAD(P)H oxidase, a superoxide-generating enzyme, in AAA. Whether or not ROS contribute to the pathogenesis of AAA, however, remains to be determined. An experimental model of aneurysm formation has recently been developed in which angiotensin II is infused into hyperlipidemic male mice. After 28 days, the mice develop AAA with histologic and pathological features that resemble AAA in humans. Angiotensin II is known to induce aortic inflammation and production of superoxide through activation of NAD(P)H oxidase, which is thought to play a role in vascular disease in humans. Preliminary data using this model indicate that levels of superoxide in the aorta of these mice are markedly increased in response to infusion of angiotensin II, preceding the formation of AAA. Here, we propose to employ a combination of pharmacological and genetic approaches to modulate ROS and NAD(P)H oxidase, and to modulate the Rho/ROCK signaling pathway, in order to investigate the role of oxidative stress in AAA formation. Our findings could have important implications with regard to the treatment of AAA in humans.
描述(由申请人提供):腹主动脉瘤(AAA)发生在大约3%的> 65岁的人中,其特征在于主动脉壁的局部结构恶化,导致进行性主动脉扩张,与AAA相关的发病率和死亡率相当高。然而,令人惊讶的是,对动脉瘤形成和进展的机制知之甚少。最近的人类组织学研究表明,AAA本质上是高度炎症性的。炎症反应与平滑肌细胞(SMC)的死亡和基质金属蛋白酶(MMP)引起的基质蛋白降解相关,基质金属蛋白酶(MMP)导致主动脉壁弱化,并因此导致扩张。鉴于活性氧(ROS)在炎症过程中产生,并可诱导SMC死亡和MMP活化,我们假设ROS在AAA形成中起关键作用。作为研究这一假设的第一步,我们检查了在选择性AAA修复术时切除的人类动脉瘤组织。我们的研究表明,超氧化物和脂质过氧化产物的水平,由氧化应激引起的组织损伤的指数,显着增加AAA与相邻的,非动脉瘤的主动脉组织从相同的患者。我们还检测到AAA中NAD(P)H氧化酶(一种超氧化物生成酶)的表达和活性增加。然而,ROS是否参与AAA的发病机制仍有待确定。最近开发了一种动脉瘤形成的实验模型,其中将血管紧张素II输注到高血压雄性小鼠中。28天后,小鼠发生AAA,其组织学和病理学特征类似于人类AAA。已知血管紧张素II通过激活NAD(P)H氧化酶诱导主动脉炎症和超氧化物的产生,NAD(P)H氧化酶被认为在人类血管疾病中起作用。使用该模型的初步数据表明,这些小鼠的主动脉中的超氧化物的水平显着增加,血管紧张素II的输液,在AAA的形成。在这里,我们建议采用药理学和遗传学的方法相结合来调节ROS和NAD(P)H氧化酶,并调节Rho/ROCK信号通路,以研究氧化应激在AAA形成中的作用。我们的发现可能对人类AAA的治疗产生重要影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Neal L Weintraub其他文献
1140-170 Hydrogen peroxide-induced superoxide production in endothelial cells: Role of nitric oxide synthase
- DOI:
10.1016/s0735-1097(04)92149-3 - 发表时间:
2004-03-03 - 期刊:
- 影响因子:
- 作者:
Christian H Coyle;Neal L Weintraub;Khalid N Kader - 通讯作者:
Khalid N Kader
Adverse thrombo-embolic events with newer tyrosine kinase inhibitors: a call to action for better risk stratification and monitoring.
新型酪氨酸激酶抑制剂的不良血栓栓塞事件:呼吁采取行动以更好地进行风险分层和监测。
- DOI:
- 发表时间:
2021 - 期刊:
- 影响因子:8.3
- 作者:
Zeeshan Hussain;L. Baldassarre;S. Dent;Neal L Weintraub;A. Guha - 通讯作者:
A. Guha
Impaired Conducted Coronary Arteriole Dilation in Patients with HFpEF
HFpEF 患者冠状动脉扩张受损
- DOI:
- 发表时间:
2017 - 期刊:
- 影响因子:0
- 作者:
Alec C. Davila;Huijuan Dou;Vijay S. Patel;D. Fulton;Neal L Weintraub;Z. Bagi - 通讯作者:
Z. Bagi
Neal L Weintraub的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Neal L Weintraub', 18)}}的其他基金
Mechanisms of myeloperoxidase and Nox4 interactions in abdominal aortic aneurysm
腹主动脉瘤中髓过氧化物酶和 Nox4 相互作用的机制
- 批准号:
9924277 - 财政年份:2018
- 资助金额:
$ 36.01万 - 项目类别:
Epigenetic regulation of HDAC9 in obesity and atherosclerosis
HDAC9 在肥胖和动脉粥样硬化中的表观遗传调控
- 批准号:
9030314 - 财政年份:2016
- 资助金额:
$ 36.01万 - 项目类别:
Perivascular adipose tissue and vascular remodeling
血管周围脂肪组织和血管重塑
- 批准号:
8686066 - 财政年份:2012
- 资助金额:
$ 36.01万 - 项目类别:
Perivascular adipose tissue and vascular remodeling
血管周围脂肪组织和血管重塑
- 批准号:
9063172 - 财政年份:2012
- 资助金额:
$ 36.01万 - 项目类别:
Perivascular adipose tissue and vascular remodeling
血管周围脂肪组织和血管重塑
- 批准号:
8394712 - 财政年份:2012
- 资助金额:
$ 36.01万 - 项目类别:
Perivascular adipose tissue and vascular remodeling
血管周围脂肪组织和血管重塑
- 批准号:
8508304 - 财政年份:2012
- 资助金额:
$ 36.01万 - 项目类别:
CD14, Surfactant Proteins, and Vascular Inflammation
CD14、表面活性蛋白和血管炎症
- 批准号:
7160705 - 财政年份:2006
- 资助金额:
$ 36.01万 - 项目类别:
Angiotensin II, oxidative stress and aneurysm formation
血管紧张素 II、氧化应激和动脉瘤形成
- 批准号:
8416977 - 财政年份:2005
- 资助金额:
$ 36.01万 - 项目类别:
Angiotensin II, oxidative stress, and aneurysm formation
血管紧张素 II、氧化应激和动脉瘤形成
- 批准号:
7373561 - 财政年份:2005
- 资助金额:
$ 36.01万 - 项目类别:
相似海外基金
Early endothelial function activation by angiotensin II receptor blockers prevents vascular damage in a model of diabetes
血管紧张素 II 受体阻滞剂早期激活内皮功能可预防糖尿病模型中的血管损伤
- 批准号:
493141 - 财政年份:2023
- 资助金额:
$ 36.01万 - 项目类别:
Clinical benefits and mechanism of action of angiotensin-II receptor blocker on Cardiovascular remodeling in patients with repaired coarctation of aorta
血管紧张素II受体阻滞剂对主动脉缩窄修复患者心血管重塑的临床疗效及作用机制
- 批准号:
10734120 - 财政年份:2023
- 资助金额:
$ 36.01万 - 项目类别:
Role of Angiotensin II in Bladder Dysfunction
血管紧张素 II 在膀胱功能障碍中的作用
- 批准号:
10707997 - 财政年份:2022
- 资助金额:
$ 36.01万 - 项目类别:
Regulation of nuclear calcium and ROS by Angiotensin II in heart cells. Régulation du calcium et ROS nucléaires par l'angiotensine II dans les cellules cardiaques.
血管紧张素 II 对心脏细胞中核钙和 ROS 的调节。
- 批准号:
RGPIN-2016-04414 - 财政年份:2022
- 资助金额:
$ 36.01万 - 项目类别:
Discovery Grants Program - Individual
Role of Angiotensin II in Bladder Dysfunction
血管紧张素 II 在膀胱功能障碍中的作用
- 批准号:
10555926 - 财政年份:2022
- 资助金额:
$ 36.01万 - 项目类别:
Regulation of nuclear calcium and ROS by Angiotensin II in heart cells. Régulation du calcium et ROS nucléaires par l'angiotensine II dans les cellules cardiaques.
血管紧张素 II 对心脏细胞中核钙和 ROS 的调节。
- 批准号:
RGPIN-2016-04414 - 财政年份:2021
- 资助金额:
$ 36.01万 - 项目类别:
Discovery Grants Program - Individual
Targeting cancer-associated fibroblasts and tumour hypoxia with angiotensin II receptor blockers
使用血管紧张素 II 受体阻滞剂靶向癌症相关成纤维细胞和肿瘤缺氧
- 批准号:
445961 - 财政年份:2021
- 资助金额:
$ 36.01万 - 项目类别:
Operating Grants
Intratubular Angiotensin II and AT1a Receptors in The Proximal Tubules: Roles in Hypertension and Kidney Injury
近曲小管中的管内血管紧张素 II 和 AT1a 受体:在高血压和肾损伤中的作用
- 批准号:
10164776 - 财政年份:2020
- 资助金额:
$ 36.01万 - 项目类别:
Novel Roles of Mitochondrial Angiotensin II in The Proximal Tubule of The Kidney
线粒体血管紧张素 II 在肾近端小管中的新作用
- 批准号:
10251271 - 财政年份:2020
- 资助金额:
$ 36.01万 - 项目类别:
Metabolic and epigenetic regulation of cancer associated fibroblasts by angiotensin II
血管紧张素 II 对癌症相关成纤维细胞的代谢和表观遗传调控
- 批准号:
440714 - 财政年份:2020
- 资助金额:
$ 36.01万 - 项目类别:
Fellowship Programs